SEC Filing Summary: Xiaobai Maimai Inc. (Form 6-K)
Business Context and Reporting Period
This Form 6-K was filed by Xiaobai Maimai Inc., a foreign private issuer headquartered in Beijing, China, for the month of December 2020. The filing was signed by Zhang Rui (Kerrie), Chief Financial Officer, on December 30, 2020. The document serves as a report pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document consists solely of the cover page and an exhibit index referencing a press release (Exhibit 99.1), but the financial data within that press release is not included in the provided text.
Material Changes
No material changes versus the prior comparable period are described in the provided text. The filing does not contain comparative financial data or narrative descriptions of operational changes.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. These details are likely contained in the referenced press release (Exhibit 99.1), which is not part of the input content.
Key Facts for Investor Verification
- Verify the content of Exhibit 99.1 (Press Release) to obtain actual financial results or material announcements for December 2020.
- Confirm the registrant's name is Xiaobai Maimai Inc., noting the discrepancy with the "Akso Health Group" label in the request metadata.
- Check subsequent filings for the full text of the press release referenced in this 6-K.